Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer? - Reply

Flynn, P., Paul, J. and Cruickshank, D. (2003) Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer? - Reply. Gynecologic Oncology, 90(2), p. 498.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Paul, Mr James
Authors: Flynn, P., Paul, J., and Cruickshank, D.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Gynecologic Oncology

University Staff: Request a correction | Enlighten Editors: Update this record